Buscar
Mostrando ítems 11-20 de 29
Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors
(2007-07-11)
An involvement of the transient receptor potential vanilloid (TRPV) 1 channel in the regulation of body temperature (T b) has not been established decisively. To provide decisive evidence for such an involvement and determine ...
Nonthermal activation of transient receptor potential vanilloid-1 channels in abdominal viscera tonically inhibits autonomic cold-defense effectors
(2007-07-11)
An involvement of the transient receptor potential vanilloid (TRPV) 1 channel in the regulation of body temperature (T b) has not been established decisively. To provide decisive evidence for such an involvement and determine ...
Adjuvantes no tratamento da hiperglicemia do diabetes melito tipo 1
(Sociedade Brasileira de Endocrinologia e Metabologia, 2008-03-01)
Since Diabetes Control and Complications Trial (DCCT), intensive therapy has been directed at achieving glucose and glycosylated hemoglobin (HbA1c) values as close to normal as possible regarding safety issues. However, ...
Immune Regulatory Properties of Allogeneic Adipose-Derived Mesenchymal Stem Cells in the Treatment of Experimental Autoimmune Diabetes
(AMER DIABETES ASSOCALEXANDRIA, 2012)
Adipose-derived mesenchymal stem cells (ADMSCs) display immunosuppressive properties, suggesting a promising therapeutic application in several autoimmune diseases, but their role in type 1 diabetes (T1D) remains largely ...
Insulin-degrading enzyme: Structure-function relationship and its possible roles in health and disease
(Bentham Science Publishers, 2009-11)
Insulin-degrading enzyme (IDE) or insulysin is a highly conserved Zn 2+-dependent endopeptidase with an "inverted" HxxEH motif. In vivo, IDE contributes to regulate the steady state levels of peripheral insulin and cerebral ...
Is “Leptin Resistance” Another Key Resistance to Manage Type 2 Diabetes?
(Bentham Science Publishers, 2020)
Although novel pharmacological options for the treatment of type 2 diabetes mellitus (DM2) have been observed to modulate the functionality of several key organs in glucose homeostasis, successful regulation of insulin ...
Alzheimer’s disease and type 2 diabetes mellitus: Pathophysiologic and pharmacotherapeutics links
(Baishideng Publishing Group Inc, 2021)
At present, Alzheimer’s disease (AD) and type 2 diabetes mellitus (T2DM) are two highly prevalent disorders worldwide, especially among elderly individuals. T2DM appears to be associated with cognitive dysfunction, with a ...
Efecto del consumo agudo de β-glucanos de avena (Avena sativa L.) sobre la saciedad y parámetros metabólicos, en sujetos aparentemente sanosEfecto del consumo agudo de β-glucanos de avena (Avena sativa L.) sobre la saciedad y parámetros metabólicos, en sujetos aparentemente sanos
(2017-03)
Los β-glucanos (βG) son polímeros lineales de glucosa de gran tamaño que forman parte de la fibra soluble de cereales como avena y cebada. Su consumo por sobre 3g/d disminuye la colesterolemia mediante la eliminación de ...
Efecto del consumo agudo de β-glucanos de avena (Avena sativa L.) sobre la saciedad y parámetros metabólicos, en sujetos aparentemente sanos
(Universidad de Chile, 2017-03)
Los β-glucanos (βG) son polímeros lineales de glucosa de gran tamaño que forman parte de la fibra soluble de cereales como avena y cebada. Su consumo por sobre 3g/d disminuye la colesterolemia mediante la eliminación de ...
Desenvolvimento e avaliação das propriedades biofarmacêuticas e farmacológicas de nanopartículas de polieletrólitos constituídas de pranlintida e sulfato de dextrana com vistas a potencial aplicação para administração nasal no tratamento do Alzheimer
(2021)
A pranlintida (Pram) é um peptídeo análogo da amilina humana, aprovada pelo FDA para tratamento do diabetes mellitus (DM) dos tipos 1 e 2, em combinação com a insulina, e para tratamento da obesidade. Além disso, tem ...